Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: A case report and a review of literature

Lupus

Volumn 17, Issue 1, 2008, Pages 50-55

  Erre, Gian Luca ^a   Pardini, S ^a   Faedda, R ^a   Passiu, G ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Anticardiolipin (antibodies); Antiphospholipid antibodies; Lupus anticoagulant; Lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; B CELL LYMPHOMA; CASE REPORT; FOLLOW UP; HUMAN; HYPOTENSION; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIPHOSPHOLIPID SYNDROME; CYCLOPHOSPHAMIDE; DOXORUBICIN; FATAL OUTCOME; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; THROMBOEMBOLISM; TREATMENT OUTCOME; VINCRISTINE;

EID: 41749105516     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307085251     Document Type: Article

References (17)

1. Hughes G. The antiphospholipid syndrome: Ten years on. Lancet 1993; 342: 341-344.
2. Veneri D, Ambrosetti A, Franchini M, Mosna F, Poli G, Pizzolo G. Remission of severe antiphospholipid syndrome associated with non-Hodgkin B cell lymphoma after combined treatment with rituximab and chemotherapy. Haematologica 2005; 90: 16-17.
3. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthrits Rheum 1999; 42: 1309-1311.
4. Trappe R, Loew A, Thuss-Patience P, Dorken B, Riess H. Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti-GP antibodies: a case report. Ann Hematol 2006; 85: 134-135.
5. Tomietto P, Gremese E, Tolusso B, Venturini P, De Vita S, Ferraccioli G. B cell depletion may lead to normalization of antiplatelet, anti-erythrocyte and antiphospholipid antibodies in systemic lupus erythematosus. Thromb Haemost 2004; 92: 1150-1153.
6. Rubenstein E, Arkfeld D, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol 2006; 33: 355-357.
7. Ames PRJ, Tommasino C, Fossati G, Scenna G, Brancaccio V, Ferrara F. Limited effect of rituximab on thrombocytopenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome. Ann Hematol 2007; 86: 227-228.
8. Cooper N, Stasi R, Cunningham-Rundles S et al. The efficacy and safety of B cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Hematol 2004; 125: 232-239.
9. Braendstrup P, Bjerrum OW, Nielsen OJ et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 2005; 78: 275-280.
10. Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C. Sustained response to rituximab of autoimmune haemolytic anaemia associated with antiphospholipid syndrome. Haematologica 2004; 89: ECR34.
11. Ahn ER, Lander G, Bidot C, Wenche Jy, Ahn YS. Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy. Am J Hematol 2005; 78: 127-129.
12. Manz RA, Arce S, Cassese G, Hauser AE, Hiepe F, Radbruch A. Humoral immunity and long-lived plasma cells. Curr Opinion Immunol 2002; 14: 517-521.
13. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid syndrome. JAMA 2006; 295: 1050-1057.
14. Harner KC, Jackson LW, Drabick JJ. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome. Rheumatology 2004; 43: 1309-1310.
15. Weide R, Heymanns J, Pandorf A, Koppler H. Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 2003; 12: 779-782.
16. Leandro MJ, Edwards JC, Cambridge G. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 2002; 61: 863-866.
17. Anandacoomarasamy A, Gibson J, Mc Gill N. "Cure" of life-threatening antiphospholipid syndrome with rituximab. Intern Med J 2006; 36: 474-475.